Eugene Braunwald

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 64

Top Topics

Atrial Fibrillation

Acute Myocardial Infarction

Top Venues

European heart journal

Circulation. Heart failure

Circulation. Cardiovascular quality and outcomes

This page only lists publications with an associated author ORCID identifier.

Publications

Brian A Bergmark, Jeong-Gun Park, Rose A Hamershock, Giorgio E M Melloni, Raffaele De Caterina, Elliott Marshall Antman, Christian T Ruff, Howard Rutman, Michele F Mercuri, Hans-Joachim Lanz, Eugene Braunwald, Robert P Giugliano
Application of the Win Ratio Method in the ENGAGE AF-TIMI 48 Trial Comparing Edoxaban With Warfarin in Patients With Atrial Fibrillation. Circulation. Cardiovascular quality and outcomes 17 (7) (2024)
Mark Colquhoun Petrie, Jean L Rouleau, Brian Lee Claggett, Karola S Jering, Peter Van der Meer, Lars Valeur Køber, Zi Michael Miao, Eldrin Lewis, Christopher B Granger, Carmine G De Pasqulae, Douglas L Mann, Phillippe Gabriel Steg, Aldo Pietro Maggioni, Offer Amir, Martin P Lefkowitz, Eugene Braunwald, Scott D Solomon, John Joseph Valentine McMurray, Marc A Pfeffer
Pulmonary Congestion and Left Ventricular Dysfunction After Myocardial Infarction: Insights From the PARADISE-MI Trial. Circulation 149 (4) (2024)
Siddharth M Patel, Eugene Braunwald, Jan Steffel, Giuseppe Boriani, Michael G Palazzolo, Elliott Marshall Antman, Erin A Bohula, Anthony P Carnicelli, Stuart J Connolly, John William Eikelboom, Baris Gencer, Christopher B Granger, David A Morrow, Manesh R Patel, Lars Wallentin, Christian T Ruff, Robert P Giugliano, null null
Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation. Circulation 149 (12) (2024)
Eugene Braunwald
Cardiology: A Century of Progress. Circulation 149 (2) (2024)
Eugene Braunwald
Cardiology: A Century of Progress. Circulation 149 (2) (2024)
Eugene Braunwald
Cardio-obstetrics: a new specialty. European heart journal 45 (18) (2024)
Eugene Braunwald
Cardio-obstetrics: a new specialty. European heart journal (2024)
Siddharth M Patel, Eugene Braunwald, Jan Steffel, Giuseppe Boriani, Michael G Palazzolo, Elliott Marshall Antman, Erin A Bohula, Anthony P Carnicelli, Stuart J Connolly, John William Eikelboom, Baris Gencer, Christopher B Granger, David A Morrow, Manesh R Patel, Lars Wallentin, Christian T Ruff, Robert P Giugliano, null null
Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of Four Randomized Clinical Trials of 58 464 Patients With Atrial Fibrillation. Circulation (2024)
Mark Colquhoun Petrie, Jean L Rouleau, Brian Lee Claggett, Karola S Jering, Peter Van der Meer, Lars Valeur Køber, Zi Michael Miao, Eldrin Lewis, Christopher B Granger, Carmine G De Pasqulae, Douglas L Mann, Phillippe Gabriel Steg, Aldo Pietro Maggioni, Offer Amir, Martin P Lefkowitz, Eugene Braunwald, Scott D Solomon, John Joseph Valentine McMurray, Marc A Pfeffer
Pulmonary Congestion and Left Ventricular Dysfunction After Myocardial Infarction: Insights From the PARADISE-MI Trial. Circulation 149 (4) (2024)
Mark Colquhoun Petrie, Jean L Rouleau, Brian Lee Claggett, Karola S Jering, Peter Van der Meer, Lars Valeur Køber, Zi Michael Miao, Eldrin Lewis, Christopher B Granger, Carmine G De Pasqulae, Douglas L Mann, Phillippe Gabriel Steg, Aldo Pietro Maggioni, Offer Amir, Martin P Lefkowitz, Eugene Braunwald, Scott D Solomon, John Joseph Valentine McMurray, Marc A Pfeffer
Pulmonary Congestion and Left Ventricular Dysfunction After Myocardial Infarction: Insights From the PARADISE-MI Trial. Circulation 149 (4) (2024)
Siddharth M Patel, Eugene Braunwald, Jan Steffel, Giuseppe Boriani, Michael G Palazzolo, Elliott Marshall Antman, Erin A Bohula, Anthony P Carnicelli, Stuart J Connolly, John William Eikelboom, Baris Gencer, Christopher B Granger, David A Morrow, Manesh R Patel, Lars Wallentin, Christian T Ruff, Robert P Giugliano, null null
Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation. Circulation 149 (12) (2024)
Eugene Braunwald
Cardiovascular effects of climate change. European heart journal 45 (33) (2024)
Carmine G De Pasquale, Brian Lee Claggett, Karola S Jering, John Joseph Valentine McMurray, Douglas L Mann, Zi Michael Miao, Christopher B Granger, Lars Valeur Køber, Aldo Pietro Maggioni, Jean-Lucien Rouleau, Scott D Solomon, Phillippe Gabriel Steg, Peter Van der Meer, Eugene Braunwald, Marc A Pfeffer
Safety and Tolerability of Angiotensin Receptor-Neprilysin Inhibitor Initiation in High-Risk Acute Myocardial Infarction Relative to Care Setting: A Subgroup Analysis of the PARADISE-MI Trial. Circulation. Heart failure (2024)
Brian A Bergmark, Jeong-Gun Park, Rose A Hamershock, Giorgio E M Melloni, Raffaele De Caterina, Elliott Marshall Antman, Christian T Ruff, Howard Rutman, Michele F Mercuri, Hans-Joachim Lanz, Eugene Braunwald, Robert P Giugliano
Application of the Win Ratio Method in the ENGAGE AF-TIMI 48 Trial Comparing Edoxaban With Warfarin in Patients With Atrial Fibrillation. Circulation. Cardiovascular quality and outcomes 17 (7) (2024)
Eugene Braunwald
Cardiology: A Century of Progress. Circulation 149 (2) (2024)
Siddharth M Patel, Eugene Braunwald, Jan Steffel, Giuseppe Boriani, Michael G Palazzolo, Elliott Marshall Antman, Erin A Bohula, Anthony P Carnicelli, Stuart J Connolly, John William Eikelboom, Baris Gencer, Christopher B Granger, David A Morrow, Manesh R Patel, Lars Wallentin, Christian T Ruff, Robert P Giugliano, null null
Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation. Circulation 149 (12) (2024)
Eugene Braunwald
Cardiovascular effects of climate change. European heart journal 45 (33) (2024)
Eugene Braunwald
Triglycerides: the past, the present, and the future. European heart journal (2024)
Brian A Bergmark, Jeong-Gun Park, Rose A Hamershock, Giorgio E M Melloni, Raffaele De Caterina, Elliott Marshall Antman, Christian T Ruff, Howard Rutman, Michele F Mercuri, Hans-Joachim Lanz, Eugene Braunwald, Robert P Giugliano
Application of the Win Ratio Method in the ENGAGE AF-TIMI 48 Trial Comparing Edoxaban With Warfarin in Patients With Atrial Fibrillation. Circulation. Cardiovascular quality and outcomes (2024)
Siddharth M Patel, Eugene Braunwald, Jan Steffel, Giuseppe Boriani, Michael G Palazzolo, Elliott Marshall Antman, Erin A Bohula, Anthony P Carnicelli, Stuart J Connolly, John William Eikelboom, Baris Gencer, Christopher B Granger, David A Morrow, Manesh R Patel, Lars Wallentin, Christian T Ruff, Robert P Giugliano, null null
Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation. Circulation 149 (12) (2024)
Eugene Braunwald
Cardiovascular effects of climate change. European heart journal (2024)
Karola S Jering, Brian Lee Claggett, Marc A Pfeffer, Christopher B Granger, Lars Valeur Køber, Eldrin F Lewis, Aldo Pietro Maggioni, Douglas L Mann, John Joseph Valentine McMurray, Margaret F Prescott, Jean L Rouleau, Scott D Solomon, Phillippe Gabriel Steg, Dirk von Lewinski, Eugene Braunwald
Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial. Circulation. Heart failure 16 (5) (2023)
Muthiah Vaduganathan, Robert J Mentz, Brian L Claggett, Zi Michael Miao, Ian J Kulac, Jonathan H Ward, Adrian F Hernandez, David A Morrow, Randall C Starling, Eric J Velazquez, Kristin M Williamson, Akshay S Desai, Shelley Zieroth, Martin Lefkowitz, John J V McMurray, Eugene Braunwald, Scott D Solomon
Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF. European heart journal (2023)
Eugene Braunwald
Control of residual dyslipidaemic risk. European heart journal 43 (39) (2023)
Eugene Braunwald
Mitochondrial cardiomyopathy: a fertile field for research. European heart journal (2023)
Eugene Braunwald
Air pollution: challenges and opportunities for cardiology. European heart journal (2023)
Eugene Braunwald
Inhibition of angiotensinogen in the treatment of hypertension. European heart journal (2023)
Eugene Braunwald
Short interfering RNA: a rapidly developing drug class. European heart journal 43 (46) (2023)
Karola S Jering, Brian Lee Claggett, Marc A Pfeffer, Christopher B Granger, Lars Valeur Køber, Eldrin F Lewis, Aldo Pietro Maggioni, Douglas L Mann, John Joseph Valentine McMurray, Margaret F Prescott, Jean L Rouleau, Scott D Solomon, Phillippe Gabriel Steg, Dirk von Lewinski, Eugene Braunwald
Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial. Circulation. Heart failure (2023)
Eugene Braunwald
Diabetocardiology: a new subspecialty? European heart journal (2023)
Eugene Braunwald
Will primordial prevention change cardiology? European heart journal (2023)
Eugene Braunwald
Short interfering RNA: a rapidly developing drug class. European heart journal 43 (46) (2023)
Karola S Jering, Brian Lee Claggett, Marc A Pfeffer, Christopher B Granger, Lars Valeur Køber, Eldrin F Lewis, Aldo Pietro Maggioni, Douglas L Mann, John Joseph Valentine McMurray, Margaret F Prescott, Jean L Rouleau, Scott D Solomon, Phillippe Gabriel Steg, Dirk von Lewinski, Eugene Braunwald
Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial. Circulation. Heart failure 16 (5) (2023)
Nishant P Shah, Darren K McGuire, Christopher P Cannon, Robert P Giugliano, Yuliya Lokhnygina, Courtney B Page, Andrew M Tershakovec, Eugene Braunwald, Michael A Blazing
Impact of Ezetimibe on New-Onset Diabetes: A Substudy of IMPROVE-IT. Journal of the American Heart Association (2023)
Eugene Braunwald, Sara Saberi, Theodore P Abraham, Perry M Elliott, Iacopo Olivotto
Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy. European heart journal (2023)
Eugene Braunwald
Control of residual dyslipidaemic risk. European heart journal 43 (39) (2023)
Karola S Jering, Brian Lee Claggett, Marc A Pfeffer, Christopher B Granger, Lars Valeur Køber, Eldrin F Lewis, Aldo Pietro Maggioni, Douglas L Mann, John Joseph Valentine McMurray, Margaret F Prescott, Jean L Rouleau, Scott D Solomon, Phillippe Gabriel Steg, Dirk von Lewinski, Eugene Braunwald
Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial. Circulation. Heart failure 16 (5) (2023)
Nicholas A Marston, Amanda C Garfinkel, Frederick K Kamanu, Giorgio M Melloni, Carolina Roselli, Petr Jarolím, David D Berg, Deepak L Bhatt, Marc P Bonaca, Christopher P Cannon, Robert P Giugliano, Michelle L O'Donoghue, Itamar Raz, Benjamin M Scirica, Eugene Braunwald, David A Morrow, Patrick T Ellinor, Steven A Lubitz, Marc S Sabatine, Christian T Ruff
A polygenic risk score predicts atrial fibrillation in cardiovascular disease. European heart journal (2022)
Christopher B Fordyce, Robert P Giugliano, Christopher P Cannon, Matthew T Roe, Abhinav Sharma, Courtney Page, Jennifer A White, Yuliya Lokhnygina, Eugene Braunwald, Michael A Blazing
Cardiovascular Events and Long-Term Risk of Sudden Death Among Stabilized Patients After Acute Coronary Syndrome: Insights From IMPROVE-IT. Journal of the American Heart Association 11 (4) (2022)
Eugene Braunwald
Cardiac xenotransplantation: a new path for the treatment of advanced heart failure? European heart journal 43 (32) (2022)
Eugene Braunwald
Short interfering RNA: a rapidly developing drug class. European heart journal 43 (46) (2022)
Eugene Braunwald
Gliflozins in the Management of Cardiovascular Disease. The New England journal of medicine 386 (21) (2022)
Marc P Bonaca, Elliott Marshall Antman, Jonathan W Cunningham, Stephen D Wiviott, Sabina A Murphy, Jonathan L Halperin, Jeffrey I Weitz, Michael A Grosso, Hans J Lanz, Eugene Braunwald, Robert P Giugliano, Christian T Ruff
Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48. European heart journal. Cardiovascular pharmacotherapy 8 (7) (2022)
Eugene Braunwald
Cardiac cell therapy: a call for action. European heart journal 43 (25) (2022)
Eugene Braunwald
Control of residual dyslipidaemic risk. European heart journal 43 (39) (2022)
Eugene Braunwald
Heart failure: a 70 year Odyssey. European heart journal 43 (18) (2022)
Eugene Braunwald
Short interfering RNA: a rapidly developing drug class. European heart journal 43 (46) (2022)
Marc P Bonaca, KyungAh Im, Giulia Magnani, Sameer Bansilal, Mikael Dellborg, Robert F Storey, Deepak L Bhatt, P Gabriel Steg, Marc Cohen, Per Johanson, Eugene Braunwald, Marc S Sabatine
Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54. European heart journal (2022)
Siddharth M Patel, Michael G Palazzolo, Sabina A Murphy, Elliot M Antman, Eugene Braunwald, Hans-Joachim Lanz, Gregory Y H Lip, Robert P Giugliano, Christian T Ruff
Evaluation of the atrial fibrillation better care pathway in the ENGAGE AF-TIMI 48 trial. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 24 (11) (2022)
Eugene Braunwald
Short interfering RNA: a rapidly developing drug class. European heart journal 43 (46) (2022)
Eugene Braunwald
Inhibitors of factor XI: game changers of anti-thrombotic therapy? European heart journal (2022)
James E Udelson, Harry P Selker, Eugene Braunwald
Glucose-Insulin-Potassium Therapy for Acute Myocardial Infarction: 50 Years On and Time for a Relook. Circulation 146 (7) (2022)
Roxana Mehran, Phillippe Gabriel Steg, Marc A Pfeffer, Karola S Jering, Brian Lee Claggett, Eldrin F Lewis, Christopher B Granger, Lars Valeur Køber, Aldo Pietro Maggioni, Douglas L Mann, John Joseph Valentine McMurray, Jean-Lucien Rouleau, Scott D Solomon, Gregory Ducrocq, Otávio Berwanger, Carmine G De Pasqulae, Ulf Landmesser, Mark Colquhoun Petrie, David Sim Kheng Leng, Peter Van der Meer, Martin Lefkowitz, Yinong Zhou, Eugene Braunwald
The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial. Circulation 146 (23) (2022)
Eugene Braunwald
Short interfering RNA: a rapidly developing drug class. European heart journal 43 (46) (2022)
Brian A Bergmark, Deepak L Bhatt, P Gabriel Steg, Andrzej Budaj, Robert F Storey, Yared Gurmu, Julia F Kuder, KyungAh Im, Giulia Magnani, Ton Oude Ophuis, Christian Hamm, Jindřich Špinar, Robert G Kiss, Frans J Van de Werf, Gilles Montalescot, Per Johanson, Eugene Braunwald, Marc S Sabatine, Marc P Bonaca
Long-Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS-TIMI 54 Trial. Journal of the American Heart Association 10 (17) (2021)
Eugene Braunwald
Reflections on Hypertrophic Cardiomyopathy. European heart journal 42 (31) (2021)
Kazuma Oyama, Robert P Giugliano, David D Berg, Christian T Ruff, Petr Jarolím, Minao Tang, Sabina A Murphy, Hans J Lanz, Michael A Grosso, Elliott Marshall Antman, Eugene Braunwald, David A Morrow
Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial. European heart journal 42 (17) (2021)
Eugene Braunwald
How to live to 100 before developing clinical coronary artery disease: a suggestion. European heart journal (2021)
Eugene Braunwald
Transseptal left heart catheterization: birth, death, and resurrection. European heart journal 42 (24) (2021)
Eugene Braunwald
Heart failure with preserved ejection fraction: a stepchild no more! European heart journal 42 (38) (2021)
Marc A Pfeffer, Brian Lee Claggett, Eldrin F Lewis, Christopher B Granger, Lars Valeur Køber, Aldo Pietro Maggioni, Douglas L Mann, John Joseph Valentine McMurray, Jean-Lucien Rouleau, Scott D Solomon, Phillippe Gabriel Steg, Otavio Berwanger, Maja Cikes, Carmine G De Pasqulae, Alberto Fernandez, Gerasimos S Filippatos, Karola S Jering, Ulf Landmesser, Venugopal Menon, Bela Merkely, Mark Colquhoun Petrie, Ivo Petrov, Morten Schou, Michele Senni, David Sim, Peter Van der Meer, Martin Lefkowitz, Yinong Zhou, Yi Wang, Eugene Braunwald
Impact of Sacubitril/Valsartan Versus Ramipril on Total Heart Failure Events in the PARADISE-MI Trial. Circulation (2021)
Eugene Braunwald
Cholesterol: the race to the bottom. European heart journal 42 (45) (2021)
Eugene Braunwald
The Birth of Cardiology: The Golden Decade. European heart journal 42 (17) (2021)
Eugene Braunwald
SGLT2 inhibitors: the statins of the 21st century. European heart journal (2021)